Amylin takes another shot at the obesity prize
Nature Reviews Drug Discovery – Drug developers are re-advancing amylin analogues for obesity, two decades since the FDA approved the first of these hormone mimetics for diabetes.
Related Articles
crossNN is an explainable framework for cross-platform DNA methylation-based classification of tumors
Nature Cancer – Yuan et al. present crossNN, an explainable machine learning tool to classify tumors based on DNA methylation data from several platforms with…
Multi-timescale reinforcement learning in the brain
Nature – Individual dopaminergic neurons encode future rewards over distinct temporal horizons.
Metabolic modeling reveals a multi-level deregulation of host-microbiome metabolic networks in IBD
Nature Communications – Here, using multi-omics, the authors reconstruct metabolic models and uncover how disrupted metabolic interactions between gut microbes and the host contribute to…
Genomics pioneer fired from firm he founded: ‘It was not easy to domesticate me’
Nature – Kári Stefánsson, who last month left the Icelandic genetics company deCODE, spoke to Nature about his legacy.
Development and validation of an autonomous artificial intelligence agent for clinical decision-making in oncology
Nature Cancer – Ferber et al. present an autonomous artificial intelligence agent system for deployment of specialized medical oncology computational tools, validating their system across…
Interfacial T cell engineering
Nature Reviews Bioengineering – The function and fate of T cells are dictated by their various dynamic interactions with cells and tissues. This Review discusses…
Why women experience Alzheimer’s disease differently from men
Nature – Sex and gender research could lead to better, more equitable treatments — if it is allowed to continue without political interference.
Cystic fibrosis
Nature Reviews Disease Primers – Cystic fibrosis is an inherited disorder involving dysfunction of the CFTR ion channel, affecting predominantly the lungs but also other…
Development and validation of an autonomous artificial intelligence agent for clinical decision-making in oncology
Nature Cancer – Ferber et al. present an autonomous artificial intelligence agent system for deployment of specialized medical oncology computational tools, validating their system across…
Development and validation of an autonomous artificial intelligence agent for clinical decision-making in oncology
Nature Cancer – Ferber et al. present an autonomous artificial intelligence agent system for deployment of specialized medical oncology computational tools, validating their system across…